Black Bird Biotech FCF per Share
Free Cash Flow per Share of Black Bird Biotech (BBBT) as of Nov 4, 2026.
Get this data via API
Financial Data API
FCF per Share
-0.00USD
YoY
-95.19%
Last updated:
Free Cash Flow per Share of Black Bird Biotech is 2023 -0.00 USD. Free Cash Flow per Share of Black Bird Biotech was 2022 -0.00 USD. It decreases by -95.19% higher compared to the previous year.
The Black Bird Biotech FCF per Share history
3 Years
10 Years
25 Years
Max
FCF per Share
Date
FCF per Share
Jan 1, 2016
-0.00 USD
Jan 1, 2017
-0.00 USD
Jan 1, 2018
-0.00 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2020
-0.00 USD
Jan 1, 2021
-0.00 USD
Jan 1, 2022
-0.00 USD
Jan 1, 2023
-0.00 USD
| YEAR | FCF per Share | YoY |
|---|---|---|
| -0.00USD | -95.19% | |
| -0.00USD | +0.30% | |
| -0.00USD | -11.78% | |
| -0.00USD | +136.49% | |
| -0.00USD | +66.92% | |
| -0.00USD | +8.07% | |
| -0.00USD | -2.89% | |
| -0.00USD | -2.78% | |
| -0.00USD | -1.70% | |
| -0.00USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Black Bird Biotech Stock analysis
What does Black Bird Biotech do? Black Bird Biotech, Inc. generates revenue through the manufacture and sale of cannabidiol (CBD) products under its brands MiteXstream, Grizzly Creek Naturals, and Black Bird American Hemp. The company's subsidiary Black Bird Potentials, Inc. (BB Potentials) produces CBD oils, gummies, pet treats, and personal care products under the Grizzly Creek Naturals brand. Big Sky American Dist., LLC (Big Sky American) distributes Grizzly Creek Naturals products alongside other consumer retail items in Western Montana, serving retail customers in that region. The firm's product portfolio targets consumers seeking CBD-infused wellness and personal care solutions across multiple segments.
BB Potentials focuses on CBD product lines including oils, gummies, and pet treats, while Black Bird American Hemp likely caters to broader hemp-based consumer markets. Big Sky American acts as a distributor for Grizzly Creek Naturals, expanding market reach in Western Montana without direct sales to end consumers. The company's revenue streams are derived from B2B distribution agreements with Big Sky American and direct sales of its branded CBD products to end consumers through various channels.
Black Bird Biotech's business model relies on a dual approach: manufacturing and branding CBD products for direct consumer sales, and partnering with Big Sky American for regional distribution. The Grizzly Creek Naturals brand is central to both direct sales and distribution, with products available in retail settings across Western Montana. The company's subsidiaries, BB Potentials and Big Sky American, facilitate production and distribution, ensuring market penetration in key geographic areas. Black Bird Biotech is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Black Bird Biotech stock
On Eulerpool you can find the complete historical development of Free Cash Flow per Share Black Bird Biotech since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — Black Bird Biotech
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Black Bird Biotech
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth